Critères de choix d'un robot de préparation des chimiothérapies injectables

Annabelle Angapin; Hail Aboudagga; Alexandre Hyvert; Andre Rieutord; Romain Desmaris

doi:10.1684/jpc.2021.0463

Critères de choix d'un robot de préparation des chimiothérapies injectables

Translated title of the contribution: Criteria for choosing a robot for injectable chemotherapy preparations

Annabelle Angapin, Hail Aboudagga, Alexandre Hyvert, Andre Rieutord, Romain Desmaris

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

In 2018, the Department of Clinical Pharmacy (DPC) opened a second centralized preparation unit for injectable chemotherapies (UCPC) sized to treat an increasing flow of preparations: 52,000 preparations in 2008 versus 80,000 in 2020. To meet the growing demand for preparations, the UCPC was enlarged in 2018 with a new controlled atmosphere area equipped with 2 ApotecaChemo robots (Loccioni) with a production start-up in February and October 2018 respectively. They increased production capacity, safety and robustness accounting for 40 up to 50% of our total daily production. In 2020, the DPC decided to acquire a third robot to increase robotic production and manage ever more complex preparations, especially for the pediatric activity. The selection criteria for this call for tenders are summarized in this analysis.

Translated title of the contribution	Criteria for choosing a robot for injectable chemotherapy preparations
Original language	French
Pages (from-to)	81-87
Number of pages	7
Journal	Journal de Pharmacie Clinique
Volume	40
Issue number	2
DOIs	https://doi.org/10.1684/jpc.2021.0463
Publication status	Published - 1 Jun 2021

Access to Document

10.1684/jpc.2021.0463

Cite this

@article{4bfc742596e5439fb393dcaf457ca914,

title = "Crit{\`e}res de choix d'un robot de pr{\'e}paration des chimioth{\'e}rapies injectables",

abstract = "In 2018, the Department of Clinical Pharmacy (DPC) opened a second centralized preparation unit for injectable chemotherapies (UCPC) sized to treat an increasing flow of preparations: 52,000 preparations in 2008 versus 80,000 in 2020. To meet the growing demand for preparations, the UCPC was enlarged in 2018 with a new controlled atmosphere area equipped with 2 ApotecaChemo robots (Loccioni) with a production start-up in February and October 2018 respectively. They increased production capacity, safety and robustness accounting for 40 up to 50% of our total daily production. In 2020, the DPC decided to acquire a third robot to increase robotic production and manage ever more complex preparations, especially for the pediatric activity. The selection criteria for this call for tenders are summarized in this analysis.",

keywords = "Call for tender, Compounding robot, Criteria selection, Injectable anticancer drugs",

author = "Annabelle Angapin and Hail Aboudagga and Alexandre Hyvert and Andre Rieutord and Romain Desmaris",

year = "2021",

month = jun,

day = "1",

doi = "10.1684/jpc.2021.0463",

language = "Fran{\c c}ais",

volume = "40",

pages = "81--87",

journal = "Journal de Pharmacie Clinique",

issn = "0291-1981",

number = "2",

}

TY - JOUR

T1 - Critères de choix d'un robot de préparation des chimiothérapies injectables

AU - Angapin, Annabelle

AU - Aboudagga, Hail

AU - Hyvert, Alexandre

AU - Rieutord, Andre

AU - Desmaris, Romain

PY - 2021/6/1

Y1 - 2021/6/1

N2 - In 2018, the Department of Clinical Pharmacy (DPC) opened a second centralized preparation unit for injectable chemotherapies (UCPC) sized to treat an increasing flow of preparations: 52,000 preparations in 2008 versus 80,000 in 2020. To meet the growing demand for preparations, the UCPC was enlarged in 2018 with a new controlled atmosphere area equipped with 2 ApotecaChemo robots (Loccioni) with a production start-up in February and October 2018 respectively. They increased production capacity, safety and robustness accounting for 40 up to 50% of our total daily production. In 2020, the DPC decided to acquire a third robot to increase robotic production and manage ever more complex preparations, especially for the pediatric activity. The selection criteria for this call for tenders are summarized in this analysis.

AB - In 2018, the Department of Clinical Pharmacy (DPC) opened a second centralized preparation unit for injectable chemotherapies (UCPC) sized to treat an increasing flow of preparations: 52,000 preparations in 2008 versus 80,000 in 2020. To meet the growing demand for preparations, the UCPC was enlarged in 2018 with a new controlled atmosphere area equipped with 2 ApotecaChemo robots (Loccioni) with a production start-up in February and October 2018 respectively. They increased production capacity, safety and robustness accounting for 40 up to 50% of our total daily production. In 2020, the DPC decided to acquire a third robot to increase robotic production and manage ever more complex preparations, especially for the pediatric activity. The selection criteria for this call for tenders are summarized in this analysis.

KW - Call for tender

KW - Compounding robot

KW - Criteria selection

KW - Injectable anticancer drugs

UR - http://www.scopus.com/inward/record.url?scp=85114624677&partnerID=8YFLogxK

U2 - 10.1684/jpc.2021.0463

DO - 10.1684/jpc.2021.0463

M3 - Article

AN - SCOPUS:85114624677

SN - 0291-1981

VL - 40

SP - 81

EP - 87

JO - Journal de Pharmacie Clinique

JF - Journal de Pharmacie Clinique

IS - 2

ER -

Critères de choix d'un robot de préparation des chimiothérapies injectables

Abstract

Access to Document

Other files and links

Cite this